Prof @UIllinoisLaw, @IllinoisMed, @IGBIllinois, @eucenter; also @CeBIL_Center #patents, #IP, #biotech, #pharma, #bioethics. Ducks, drugs, and nicks that roll.
Sep 11, 2020 • 51 tweets • 11 min read
Alright, every, time to take a break from our dystopian hellscape and get back to some fun stuff—the *just out* #CRISPR#patent interference decision. What does it mean? What happened? What happens next?
This is a Tweetstorm. Come along and ride with me: /1
First, a bit of history. As you may remember, we've been here before. Broad & UC had a previous interference that focused on CRISPR-Cas9 *eukaryotic* claims back in 2016/2017, affirmed by the CAFC in 2018. /2
May 18, 2020 • 40 tweets • 7 min read
Alright everyone! It's been a long time, but here's a tweetstorm on the 2d oral argument in the #CRISPR#patent case between the Broad Institute and U.C.—it just concluded minutes ago. /1
For those who have been following this second round, this second interference concerns several of Broad's patents—and UC patents—issued *after* the first interference. Here's the docket: acts.uspto.gov/ifiling/Public… it's Interference No. 106,115 /2
